NIR-II Photoresponsive Magnetoliposomes for Remote-Controlled Release and Magnetic Resonance Imaging

Area of Science:

• Biomedical Engineering
• Nanomedicine
• Materials Science

Background:

• Iron oxide nanoparticles (IONPs) are crucial in nanomedicine due to their magnetic properties and biocompatibility.
• Liposomes enhance IONP functionality, enabling drug coencapsulation and improved molecular imaging.
• Combining these creates magnetoliposomes (LP-IONPs) for advanced therapeutic applications.

Purpose of the Study:

• To develop dual T2-T1 MRI contrast agents for image-guided liposome degradation.
• To create infrared light-responsive nanocarriers for remote-controlled drug delivery in the second biological window.
• To evaluate LP-IONPs for in vivo applications in cancer treatment.

Main Methods:

• Fabrication of magnetoliposomes (LP-IONPs) with ultrasmall IONPs and thermoresponsive phospholipids.
• Utilizing dynamic T2-to-T1 MRI contrast shift during intracellular LP-IONP degradation.
• Implementing infrared light-triggered drug release in cancer cells.
• Conducting biodistribution studies using MRI and histological analysis.

Main Results:

• Demonstrated a dynamic T2-to-T1 MRI contrast shift correlating with LP-IONP degradation.
• Achieved successful light-activated drug release in cancer cells.
• Confirmed in vivo applicability through biodistribution and histological assessments.

Conclusions:

• LP-IONPs function as effective dual MRI contrast agents for image-guided therapy.
• These nanocarriers enable remote-controlled drug delivery via infrared light activation.
• LP-IONPs show significant potential for advanced image-guided and remote-controlled drug delivery systems.